Androgen Receptor Signaling in Bladder Cancer

被引：79

作者：

Li, Peng ^{[1
,2
,3
]}

Chen, Jinbo ^{[4
,5
,6
]}

Miyamoto, Hiroshi ^{[1
,2
,4
,5
,7
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA

[2] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA

[3] Shandong Univ, Shandong Prov Hosp Affiliated, Minimally Invas Urol Ctr, Jinan 250021, Peoples R China

[4] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA

[5] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA

[6] Cent South Univ, Xiangya Hosp, Dept Urol, Changsha 410008, Hunan, Peoples R China

[7] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA

来源：

CANCERS | 2017年 / 9卷 / 02期

关键词：

androgen; androgen receptor; anti-androgen; carcinogenesis; tumor progression; urothelial cancer; LOWER URINARY-TRACT; TRANSITIONAL-CELL-CARCINOMA; STEROID-HORMONE RECEPTORS; DEPRIVATION THERAPY; PROGNOSTIC-SIGNIFICANCE; UROTHELIAL CARCINOMA; ESTROGEN-RECEPTORS; EXPRESSION; PROGRESSION; GROWTH;

D O I：

10.3390/cancers9020020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Emerging preclinical findings have indicated that steroid hormone receptor signaling plays an important role in bladder cancer outgrowth. In particular, androgen-mediated androgen receptor signals have been shown to correlate with the promotion of tumor development and progression, which may clearly explain some sex-specific differences in bladder cancer. This review summarizes and discusses the available data, suggesting the involvement of androgens and/or the androgen receptor pathways in urothelial carcinogenesis as well as tumor growth. While the precise mechanisms of the functions of the androgen receptor in urothelial cells remain far from being fully understood, current evidence may offer chemopreventive or therapeutic options, using androgen deprivation therapy, in patients with bladder cancer.

引用

页数：14

共 97 条

[1]

[Anonymous], J ENDOCRINOL

[2]

[Anonymous], BMC UROL

[3] Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting [J].

Antonarakis, E. S. ;

Armstrong, A. J. ;

Dehm, S. M. ;

Luo, J. .

PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (03) :231-241

[4] SPECIFIC INDUCTION OF BLADDER CANCER IN MICE BY BUTYL-(4-HYDROXYBUTYL)-NITROSAMINE AND EFFECTS OF HORMONAL MODIFICATIONS ON SEX DIFFERENCE IN RESPONSE [J].

BERTRAM, JS ;

CRAIG, AW .

EUROPEAN JOURNAL OF CANCER, 1972, 8 (06) :587-&

[5] The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage [J].

Bhattacharya, Arup ;

Klaene, Joshua J. ;

Li, Yun ;

Paonessa, Joseph D. ;

Stablewski, Aimee B. ;

Vouros, Paul ;

Zhang, Yuesheng .

ONCOTARGET, 2015, 6 (02) :836-845

[6] Receptor mechanisms mediating non-genomic actions of sex steroids [J].

Boonyaratanakornkit, Viroj ;

Edwards, Dean P. .

SEMINARS IN REPRODUCTIVE MEDICINE, 2007, 25 (03) :139-153

[7] Androgjen receptor expression is inversely correlated with pathologic, tumor stage in bladder cancer [J].

Boorjian, S ;

Ugras, S ;

Mongan, NP ;

Gudas, LJ ;

You, XK ;

Tickoo, SK ;

Scherr, DS .

UROLOGY, 2004, 64 (02) :383-388

[8] Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder [J].

Boorjian, Stephen A. ;

Heemers, Hannelore V. ;

Frank, Igor ;

Farmer, Sara A. ;

Schmidt, Lucy J. ;

Sebo, Thomas J. ;

Tindall, Donald J. .

[9] Emerging therapeutic targets in bladder cancer [J].

Carneiro, Benedito A. ;

Meeks, Joshua J. ;

Kuzel, Timothy M. ;

Scaranti, Mariana ;

Abdulkadir, Sarki A. ;

Giles, Francis J. .

CANCER TREATMENT REVIEWS, 2015, 41 (02) :170-178

[10] The sex hormone receptors in the bladder in childhood I:: Preliminary report in male subjects [J].

Celayir, S ;

Ilçe, Z ;

Dervisoglu, S .

EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2002, 12 (05) :312-317

← 1 2 3 4 5 6 7 8 9 10 →